Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8237)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2015 (publication date) through Feb 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He XW, Feng T, Yin QL, Jian YW, Liu T. NOB1 is essential for the survival of RKO colorectal cancer cells. World J Gastroenterol 2015; 21(3): 868-877 [PMID: 25624720 DOI: 10.3748/wjg.v21.i3.868] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i3/868.htm |
| Number | Citing Articles |
| 1 |
Xin Gao, Xinlong Fan, Wei Zeng, Jiwang Liang, Nan Guo, Xiao Yang, Yuejiao Zhao. Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu). Bioengineered 2022; 13(3): 7880 doi: 10.1080/21655979.2022.2051266
|
| 2 |
Yubo Ma, Wei Zhou, Liu Hong, Zhongjun Wu. Establishment of a Novel Monoclonal Antibody L6 Specific to NOB1. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2016; 35(2): 100 doi: 10.1089/mab.2015.0065
|
| 3 |
Qing‑Hua Wang, Min Zhang, Ming‑Hui Zhou, Xiao‑Jiao Gao, Fang Chen, Xun Yan, Feng Lu. High expression of eukaryotic initiation factor�3M predicts poor prognosis in colon adenocarcinoma patients. Oncology Letters 2019; doi: 10.3892/ol.2019.11164
|
| 4 |
Chan Hum Park, Min Jo Kim, Chang Yeol Yang, Takako Yokozawa, Yu Su Shin. Safflower seed extract synergizes the therapeutic effect of cisplatin and reduces cisplatin-induced nephrotoxicity in human colorectal carcinoma RKO cells and RKO-transplanted mice. Drug Discoveries & Therapeutics 2019; 13(6): 328 doi: 10.5582/ddt.2019.01086
|
| 5 |
Sheqing Ji, Bin Zhang, Ye Kong, Fei Ma, Yawei Hua. miR-326 Inhibits Gastric Cancer Cell Growth Through Downregulating NOB1. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(6): 853 doi: 10.3727/096504016X14759582767486
|
| 6 |
Jiandong Wang, Lei Cao, Jianhong Wu, Qiugen Wang. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma. International Journal of Oncology 2017; doi: 10.3892/ijo.2017.4187
|
| 7 |
Leiming Luo, Yuanhui Wang, Yiran Yin, Jianhua Ge, Xiaobo Lu. Effects of NOB1 on the pathogenesis of osteosarcoma and its expression on the chemosensitivity to cisplatin. Oncology Letters 2018; doi: 10.3892/ol.2018.7730
|
| 8 |
JIANTAO SUN, ZHIQIANG FAN, SHUAIQI LU, JINHUI YANG, TONGTONG HAO, QINGXIANG HUO. miR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein. International Journal of Molecular Medicine 2016; 37(2): 485 doi: 10.3892/ijmm.2016.2449
|
| 9 |
Weiwei Ke, Zaiming Lu, Xiangxuan Zhao. NOB1: A Potential Biomarker or Target in Cancer. Current Drug Targets 2019; 20(10): 1081 doi: 10.2174/1389450120666190308145346
|
| 10 |
XIN GAO, JIN WANG, WEILIANG BAI, WENYUE JI, LIPING WANG. NOB1 silencing inhibits the growth and metastasis of laryngeal cancer cells through the regulation of JNK signaling pathway. Oncology Reports 2016; 35(6): 3313 doi: 10.3892/or.2016.4707
|
| 11 |
Yongtao Zhang, Fang Wang, Lina Wang, Quanbin Zhang. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01859-y
|
| 12 |
Haixia Liu, Jing Guo, Hongyan Chai, Xiangfeng Meng. MicroRNA‑744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.9826
|
| 13 |
Jie Li, Liya Liu, Youqin Chen, Meizhu Wu, Xiaoying Lin, Zhiqing Shen, Ying Cheng, Xiaoping Chen, Nathaniel Weygant, Xiangyan Wu, Lihui Wei, Thomas Sferra, Yuying Han, Xi Chen, Aling Shen, Aling Shen, Jun Peng. Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple‑negative breast cancer. Oncology Reports 2022; 47(6) doi: 10.3892/or.2022.8319
|
| 14 |
Zhong Ren, Liqing Yao, Jingzheng Liu, Zhipeng Qi, Jian Li. Silencing NOB1 Can Affect Cell Proliferation and Apoptosis Via the C-Jun N-Terminal Kinase Pathway in Colorectal Cancer. Journal of Investigative Surgery 2021; 34(8): 819 doi: 10.1080/08941939.2019.1697401
|
| 15 |
Ping Huang, Jie Xi, Shikai Liu. MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1. Biomedicine & Pharmacotherapy 2016; 83: 850 doi: 10.1016/j.biopha.2016.07.050
|
| 16 |
Long‑Ci Sun, Hai‑Xin Qian. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8862
|
| 17 |
Huajia Dai, Kezhu Hou, Zujin Cai, Qi Zhou, Song Zhu. Low‑level miR‑646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression. Oncology Letters 2017; doi: 10.3892/ol.2017.7032
|